製薬CROの世界市場

製薬CROの世界市場は2030年までに551億米ドルに到達

2024年に400億米ドルと推定される製薬CROの世界市場は、2024年から2030年にかけてCAGR 5.5%で成長し、2030年には551億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである創薬は、CAGR4.6%を記録し、分析期間終了時には342億米ドルに達すると予想されます。プレクリニカル分野の成長率は、分析期間中CAGR 7.2%と推定されます。

米国市場は109億米ドルと推定、中国はCAGR 8.5％で成長予測

米国の製薬CRO市場は2024年に109億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに110億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と5.4%と予測されています。欧州では、ドイツがCAGR 3.5%で成長すると予測されています。

世界の製薬CRO市場- 主要動向と促進要因まとめ

製薬CROとは何か？

医薬品開発業務受託機関（CRO）とは、製薬、バイオテクノロジー、医療機器業界に委託研究サービスを提供する企業です。これらのサービスには、臨床試験管理、医薬品開発、規制遵守、ラボ試験などが含まれます。CROは、臨床試験のデザイン、実施、分析において製薬会社をサポートし、多くの場合、初期段階の研究から市場開拓まで、医薬品開発の運営面を担当します。

製薬CROは、製薬会社が専門知識を利用し、コストを削減し、医薬品開発期間を短縮することで、業界に利益をもたらします。CROにアウトソーシングすることで、製薬会社は創薬などのコアコンピタンスに集中できる一方、CROの業務や技術に関する専門知識を活用することで、より効率的な開発プロセスを実現することができます。CROはまた、患者募集、規制遵守、データ解析など、複雑な臨床試験の管理も支援し、医薬品開発プロジェクトが必要な科学的・規制的基準を満たすようにします。CROと提携することで、製薬会社はますます複雑化し、コストのかかる医薬品開発の現場を、より機敏に、より低い投資リスクで乗り切ることができます。

なぜ製薬CRO市場は拡大しているのか？

製薬CRO市場は、製薬企業による研究開発費の増加、アウトソーシングサービスに対する需要の高まり、臨床試験の複雑化など、いくつかの重要な要因により拡大しています。市場成長の主な促進要因の1つは、製薬企業による研究開発（R&D）投資の増加です。製薬業界が革新的な新薬開発へのプレッシャーの高まりに直面する中、研究開発費は増加し、CROサービスへの需要を牽引しています。CROは、臨床試験、製剤化、薬事申請など、専門知識を必要とする研究開発プロジェクトの管理・遂行において、製薬企業を支援する重要な役割を担っています。

アウトソーシングの動向も、製薬CRO市場の拡大に寄与する重要な要因の一つです。製薬会社は、業務コストの削減と効率化のために、外部のサービス・プロバイダーを利用するようになってきています。臨床試験、ラボ試験、薬事業務などの非中核業務をアウトソーシングすることで、製薬会社は創薬や商品化などのコアコンピタンスに集中することができます。また、アウトソーシングを利用することで、社内にインフラを構築することなく、迅速に業務を拡大し、専門的な知識を利用することができます。このようなアウトソーシングへのシフトは、CROサービスに対する需要を大幅に増加させ、市場の成長を牽引しています。

臨床試験の複雑化も市場拡大の原動力となっています。個別化医薬品の需要増加、国際共同治験の必要性、生物製剤や遺伝子治療の台頭などの要因により、臨床試験は複雑化しています。CROは、患者募集、試験デザイン、法規制遵守、世界・ロジスティクスなどの分野で専門知識を提供し、これらの複雑性を管理するのに適した能力を備えています。臨床試験が進化するにつれ、製薬会社はますます複雑化する医薬品開発プロセスをナビゲートするためにCROへの依存度を高めており、これが製薬CRO市場の成長にさらに貢献しています。

製薬CRO市場の将来を形作る主要動向とは？

個別化医療への注目の高まり、臨床試験技術の進歩、戦略的パートナーシップの台頭など、いくつかの主要動向が製薬CRO市場の将来を形成しています。最も重要な動向のひとつは、個別化医療に対する需要の高まりです。製薬企業が特定の患者集団や遺伝子プロファイルに合わせた治療を開発する傾向が強まるにつれ、専門的な臨床試験や個別化された医薬品開発プロセスの必要性が高まっています。CROは、バイオマーカー検査、遺伝子プロファイリング、臨床試験における患者の層別化など、精密医療に焦点を当てたサービスを提供することで、この傾向に適応しています。このような個別化治療へのシフトは、今後も製薬CRO市場の将来を形作るものと予想され、各社は個別化治療の需要に対応するため、より専門的なソリューションを提供しています。

臨床試験技術の進歩も製薬CRO市場の将来に影響を与えています。データ分析、人工知能（AI）、ウェアラブルデバイスなどのデジタル技術の活用は、臨床試験のデザインと実施に革命をもたらしています。CROは、患者募集の強化、試験モニタリングの改善、従来の臨床試験に関連するコストと時間の削減のために、これらの技術を採用しています。例えば、AIは患者データの解析や臨床転帰の予測に活用されており、ウェアラブル端末は患者の健康状態をリアルタイムでモニタリングし、データ収集と試験の効率化を支援します。こうした技術の進歩により、臨床試験の効果とスピードが大幅に向上し、製薬CRO市場の成長がさらに促進されると期待されています。

製薬企業とCROの戦略的パートナーシップの台頭も、市場の将来を形作る重要な動向です。多くの製薬企業は、研究開発能力の強化、イノベーションの向上、新薬の市場投入期間の短縮を目的として、CROと長期的な提携関係を結んでいます。このような提携により、製薬企業はCROの臨床試験管理、規制遵守、データ分析などの専門知識を活用できるようになると同時に、CROにより安定した収益源を提供できるようになります。新薬開発の複雑さが増すにつれ、戦略的パートナーシップはより一般的になり、製薬CROサービスの需要をさらに押し上げると予想されます。

製薬CRO市場の成長促進要因は？

製薬CRO市場の成長は、研究開発サービスに対する需要の増加、医薬品開発の複雑化、新興国市場の台頭など、いくつかの要因によってもたらされます。主な要因の一つは、研究開発サービスに対する需要の増加です。製薬会社が革新的な新薬の開発に注力し続ける中、外部の研究開発専門家に対するニーズが高まっています。CROは、臨床試験のデザイン・管理、薬事申請、ラボ試験に必要な専門知識とインフラを提供し、医薬品開発プロセスにおける貴重なパートナーとなっています。新薬の迅速かつ効率的な市場投入への注目が高まるにつれ、アウトソーシングされた研究開発サービスへの需要が高まっており、これが製薬CRO市場の成長を後押ししています。

医薬品開発の複雑化も市場成長の主な要因です。生物製剤、遺伝子治療、個別化医療の台頭により、臨床試験はより複雑化し、専門的な知識、技術、専門知識が必要とされるようになっています。CROは、患者募集からデータ収集、規制遵守、試験モニタリングに至るまで、医薬品開発の複雑性を管理する上で不可欠なパートナーと見なされるようになっています。医薬品開発が複雑化するにつれ、製薬会社はこれらの課題を解決するためにCROへの依存度を高めており、CROのサービスへの需要が高まっています。

新興市場の台頭も製薬CRO市場の成長に寄与しています。多くの製薬企業が、アジア太平洋、ラテンアメリカ、アフリカなどの新興市場に研究開発および臨床試験事業を拡大しています。これらの地域は、人口が多く多様性に富み、運営コストが比較的低く、規制環境も進化しているため、臨床試験にとって大きなチャンスとなります。世界の能力を持つCROは、これらの地域の製薬企業をサポートするのに適した立場にあり、臨床試験ネットワークの拡大や新市場への参入を支援しています。新興市場への医薬品研究開発の拡大は、CROサービスに対する需要を促進し、市場成長をさらに後押ししています。

最後に、製薬業界におけるコスト抑制傾向の高まりも市場成長の促進要因です。製薬会社は、高い品質水準とコンプライアンスを維持しながら、コスト削減と効率化を図る必要に迫られています。研究開発機能をCROにアウトソーシングすることで、製薬企業は運営コストを削減し、インフラへの大規模な設備投資を回避し、専門的な知識を得ることができます。このようなコスト抑制の動向は、イノベーションと規制遵守の高いレベルを維持しながら研究開発プロセスの最適化を目指す企業にとって、今後も製薬CRO市場の成長を牽引するものと思われます。

セグメント

タイプ（創薬、前臨床、臨床）、分子タイプ（低分子、高分子）、サービス（プロジェクト管理/臨床供給管理、データ管理、薬事/メディカルアフェアーズ、メディカルライティング、臨床モニタリング、品質管理/保証、生物統計、治験責任医師支払い、ラボ、患者/施設募集、テクノロジー、その他）、治療領域（腫瘍学、中枢神経系疾患、感染症、免疫疾患、心血管疾患、呼吸器疾患、糖尿病、眼科、疼痛管理、その他）

調査対象企業の例

• BioAgile Therapeutics
• Celerion
• Charles River Laboratories
• Ergomed
• Frontage Laboratories
• ICON plc
• IQVIA
• KCR
• Linical
• Medpace
• Novotech
• Parexel International
• Pharm-Olam
• PPD（Thermo Fisher Scientific）
• Premier Research
• PSI CRO
• Sofpromed
• Syneos Health
• Worldwide Clinical Trials
• WuXi AppTec

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Pharmaceutical CRO Market to Reach US$55.1 Billion by 2030

The global market for Pharmaceutical CRO estimated at US$40.0 Billion in the year 2024, is expected to reach US$55.1 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Drug Discovery, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$34.2 Billion by the end of the analysis period. Growth in the Pre-Clinical segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.9 Billion While China is Forecast to Grow at 8.5% CAGR

The Pharmaceutical CRO market in the U.S. is estimated at US$10.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.0 Billion by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Pharmaceutical CRO Market - Key Trends & Drivers Summarized

What Is a Pharmaceutical CRO and How Does It Benefit the Industry?

A Pharmaceutical Contract Research Organization (CRO) is a company that provides outsourced research services to the pharmaceutical, biotechnology, and medical device industries. These services include clinical trial management, drug development, regulatory compliance, laboratory testing, and more. CROs support pharmaceutical companies in the design, implementation, and analysis of clinical trials, often handling the operational aspects of drug development, from early-stage research through to market launch.

Pharmaceutical CROs benefit the industry by allowing pharmaceutical companies to access specialized expertise, reduce costs, and speed up drug development timelines. Outsourcing to CROs helps pharmaceutical companies focus on their core competencies, such as drug discovery, while leveraging the operational and technical expertise of CROs for more efficient development processes. CROs also help manage the complexities of clinical trials, including patient recruitment, regulatory compliance, and data analysis, ensuring that drug development projects meet the necessary scientific and regulatory standards. By partnering with CROs, pharmaceutical companies can navigate the increasingly complex and expensive landscape of drug development with more agility and lower investment risk.

Why Is the Pharmaceutical CRO Market Expanding?

The pharmaceutical CRO market is expanding due to several key factors, including increasing R&D spending by pharmaceutical companies, the rising demand for outsourced services, and the growing complexity of clinical trials. One of the major drivers of market growth is the rising investment in research and development (R&D) by pharmaceutical companies. As the pharmaceutical industry faces increasing pressure to develop new and innovative drugs, R&D spending has been rising, driving demand for CRO services. CROs play a vital role in helping pharmaceutical companies manage and execute R&D projects, including clinical trials, drug formulation, and regulatory submissions, all of which require specialized expertise.

The growing trend of outsourcing is another key factor contributing to the expansion of the pharmaceutical CRO market. Pharmaceutical companies are increasingly looking to external service providers to reduce operational costs and improve efficiency. By outsourcing non-core activities such as clinical trials, laboratory testing, and regulatory affairs, pharmaceutical companies can focus on their core competencies, such as drug discovery and commercialization. Outsourcing also allows companies to scale operations quickly and access specialized expertise without the need to build internal infrastructure. This shift toward outsourcing has significantly increased the demand for CRO services, driving the growth of the market.

The growing complexity of clinical trials is also driving the market’s expansion. Clinical trials are becoming more complex due to factors such as the increasing demand for personalized medicines, the need for international trials, and the rise of biologics and gene therapies. CROs are better equipped to manage these complexities, offering expertise in areas such as patient recruitment, trial design, regulatory compliance, and global logistics. As clinical trials evolve, pharmaceutical companies are relying more on CROs to navigate the increasingly intricate process of drug development, which is further contributing to the growth of the pharmaceutical CRO market.

What Key Trends Are Shaping the Future of the Pharmaceutical CRO Market?

Several key trends are shaping the future of the pharmaceutical CRO market, including the growing focus on personalized medicine, advancements in clinical trial technology, and the rise of strategic partnerships. One of the most significant trends is the growing demand for personalized medicine. As pharmaceutical companies increasingly develop treatments tailored to specific patient populations or genetic profiles, the need for specialized clinical trials and personalized drug development processes is rising. CROs are adapting to this trend by offering services that focus on precision medicine, including biomarker testing, genetic profiling, and patient stratification in clinical trials. This shift towards personalized treatments is expected to continue shaping the future of the pharmaceutical CRO market, with companies offering more specialized solutions to meet the demands of personalized therapies.

Advancements in clinical trial technology are also influencing the future of the pharmaceutical CRO market. The use of digital technologies, such as data analytics, artificial intelligence (AI), and wearable devices, is revolutionizing clinical trial design and execution. CROs are adopting these technologies to enhance patient recruitment, improve trial monitoring, and reduce the costs and time associated with traditional clinical trials. For example, AI is being used to analyze patient data and predict clinical outcomes, while wearable devices help monitor patient health in real-time, improving data collection and trial efficiency. These technological advancements are expected to significantly improve the effectiveness and speed of clinical trials, further driving the growth of the pharmaceutical CRO market.

The rise of strategic partnerships between pharmaceutical companies and CROs is another key trend shaping the market’s future. Many pharmaceutical companies are entering long-term collaborations with CROs to enhance their R&D capabilities, improve innovation, and speed up the time-to-market for new drugs. These partnerships allow pharmaceutical companies to tap into the CRO’s expertise in clinical trial management, regulatory compliance, and data analysis while providing CROs with more stable revenue streams. As the complexity of drug development increases, strategic partnerships are expected to become more common, further boosting the demand for pharmaceutical CRO services.

What Are the Key Drivers of Growth in the Pharmaceutical CRO Market?

The growth in the pharmaceutical CRO market is driven by several factors, including the increasing demand for R&D services, the growing complexity of drug development, and the rise of emerging markets. One of the primary drivers is the increasing demand for research and development services. As pharmaceutical companies continue to focus on developing new and innovative therapies, the need for external R&D expertise has grown. CROs offer the specialized knowledge and infrastructure required for the design and management of clinical trials, regulatory submissions, and laboratory testing, making them valuable partners in the drug development process. The increasing focus on bringing new drugs to market quickly and efficiently is driving the demand for outsourced R&D services, which is fueling the growth of the pharmaceutical CRO market.

The growing complexity of drug development is another key driver of market growth. With the rise of biologics, gene therapies, and personalized medicine, clinical trials are becoming more intricate, requiring specialized knowledge, technology, and expertise. CROs are increasingly seen as essential partners in managing the complexities of drug development, from patient recruitment and data collection to regulatory compliance and trial monitoring. As drug development becomes more complex, pharmaceutical companies are relying more on CROs to navigate these challenges, driving demand for their services.

The rise of emerging markets is also contributing to the growth of the pharmaceutical CRO market. Many pharmaceutical companies are expanding their R&D and clinical trial operations into emerging markets such as Asia-Pacific, Latin America, and Africa. These regions offer significant opportunities for clinical trials due to their large, diverse populations, relatively lower operational costs, and evolving regulatory environments. CROs with global capabilities are well-positioned to support pharmaceutical companies in these regions, helping them expand their clinical trial networks and access new markets. The expansion of pharmaceutical R&D into emerging markets is driving the demand for CRO services, further fueling market growth.

Lastly, the growing trend of cost containment in the pharmaceutical industry is another driver of market growth. Pharmaceutical companies are under increasing pressure to reduce costs and improve efficiency while maintaining high standards of quality and compliance. By outsourcing R&D functions to CROs, pharmaceutical companies can lower operational costs, avoid large capital investments in infrastructure, and gain access to specialized expertise. This trend toward cost containment is likely to continue driving the growth of the pharmaceutical CRO market as companies seek to optimize their R&D processes while maintaining high levels of innovation and regulatory compliance.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical CRO market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Drug Discovery, Pre-Clinical, Clinical); Molecule Type (Small Molecules, Large Molecules); Service (Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Others); Therapeutic Areas (Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• BioAgile Therapeutics
• Celerion
• Charles River Laboratories
• Ergomed
• Frontage Laboratories
• ICON plc
• IQVIA
• KCR
• Linical
• Medpace
• Novotech
• Parexel International
• Pharm-Olam
• PPD (Thermo Fisher Scientific)
• Premier Research
• PSI CRO
• Sofpromed
• Syneos Health
• Worldwide Clinical Trials
• WuXi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Pharmaceutical CRO - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Complexity of Clinical Trials and Protocol Designs Drives Reliance on Full-Service Global CROs
  • Shift Toward Virtual, Decentralized, and Hybrid Trials Spurs Investment in Digital and Remote Monitoring Capabilities
  • Surging Drug Development Activity Across Oncology, CNS, and Rare Diseases Expands Need for Specialized CRO Expertise
  • Acceleration of Early-Phase Studies by Biotech Startups Drives Demand for End-to-End CRO Support Models
  • Globalization of Clinical Trials Creates Need for CROs With Regulatory Knowledge and Site Networks Across Regions
  • Increasing Pressure to Shorten Development Timelines Encourages Agile CRO Partnerships With Flexible Engagement Models
  • Adoption of Risk-Based Monitoring and Real-World Evidence Enhances CRO Value Proposition and Trial Efficiency
  • Integration of AI, Big Data, and Predictive Analytics Strengthens Protocol Design and Patient Recruitment Strategies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pharmaceutical CRO Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pharmaceutical CRO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pharmaceutical CRO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Pharmaceutical CRO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Clinical Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Clinical Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Clinical Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Quality Management / Assurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Quality Management / Assurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Quality Management / Assurance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Biostatistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Biostatistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Biostatistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Investigator Payments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Investigator Payments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Investigator Payments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Patient & Site Recruitment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Patient & Site Recruitment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Patient & Site Recruitment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Project Management / Clinical Supply Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Project Management / Clinical Supply Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Project Management / Clinical Supply Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Data Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Data Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Data Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Regulatory / Medical Affairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Regulatory / Medical Affairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Regulatory / Medical Affairs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Medical Writing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Medical Writing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Medical Writing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for CNS Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for CNS Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for CNS Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Immunological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Immunological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Immunological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Cardiovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Cardiovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: World 15-Year Perspective for Cardiovascular Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 65: World Recent Past, Current & Future Analysis for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: World Historic Review for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: World 15-Year Perspective for Respiratory Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 68: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 71: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 72: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 74: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: World 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 77: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 80: World Recent Past, Current & Future Analysis for Small Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: World Historic Review for Small Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: World 15-Year Perspective for Small Molecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 83: World Recent Past, Current & Future Analysis for Large Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: World Historic Review for Large Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: World 15-Year Perspective for Large Molecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 86: USA Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: USA Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: USA 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 89: USA Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: USA Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: USA 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 92: USA Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: USA Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: USA 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 95: USA Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: USA Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: USA 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 98: Canada Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Canada Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Canada 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 101: Canada Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Canada Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Canada 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 104: Canada Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Canada Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Canada 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 107: Canada Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Canada Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Canada 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• JAPAN
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 110: Japan Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Japan Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Japan 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 113: Japan Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Japan Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Japan 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 116: Japan Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Japan Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Japan 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 119: Japan Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Japan Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Japan 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• CHINA
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 122: China Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: China Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: China 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 125: China Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: China Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: China 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 128: China Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: China Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: China 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 131: China Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: China Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: China 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• EUROPE
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 134: Europe Recent Past, Current & Future Analysis for Pharmaceutical CRO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 135: Europe Historic Review for Pharmaceutical CRO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Europe 15-Year Perspective for Pharmaceutical CRO by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 137: Europe Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Europe Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Europe 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 140: Europe Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Europe Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Europe 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 143: Europe Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Europe Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Europe 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 146: Europe Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Europe Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Europe 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• FRANCE
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 149: France Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: France Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: France 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 152: France Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: France Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: France 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 155: France Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: France Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: France 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 158: France Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: France Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: France 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• GERMANY
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 161: Germany Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Germany Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Germany 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 164: Germany Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Germany Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Germany 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 167: Germany Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Germany Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Germany 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 170: Germany Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Germany Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Germany 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 173: Italy Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Italy Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Italy 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 176: Italy Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Italy Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Italy 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 179: Italy Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Italy Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Italy 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 182: Italy Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Italy Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Italy 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 185: UK Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: UK Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: UK 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 188: UK Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: UK Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: UK 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 191: UK Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UK Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: UK 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 194: UK Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UK Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: UK 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 197: Spain Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Spain Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Spain 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 200: Spain Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Spain Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Spain 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 203: Spain Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Spain Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Spain 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 206: Spain Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Spain Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Spain 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 209: Russia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Russia Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Russia 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 212: Russia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Russia Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Russia 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 215: Russia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Russia Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Russia 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 218: Russia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Russia Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Russia 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 221: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Rest of Europe Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Rest of Europe 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Europe Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Rest of Europe 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Europe Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Europe 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Europe Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Europe 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 233: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical CRO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 234: Asia-Pacific Historic Review for Pharmaceutical CRO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Asia-Pacific 15-Year Perspective for Pharmaceutical CRO by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 236: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Asia-Pacific Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Asia-Pacific 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 239: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Asia-Pacific Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Asia-Pacific 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Asia-Pacific Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Asia-Pacific 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Asia-Pacific Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Asia-Pacific 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 248: Australia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Australia Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Australia 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 251: Australia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Australia Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Australia 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 254: Australia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Australia Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Australia 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 257: Australia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Australia Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Australia 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• INDIA
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 260: India Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: India Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: India 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 263: India Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: India Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: India 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 266: India Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: India Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: India 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 269: India Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: India Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: India 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 272: South Korea Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: South Korea Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: South Korea 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 275: South Korea Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: South Korea Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: South Korea 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 278: South Korea Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: South Korea Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: South Korea 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 281: South Korea Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: South Korea Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: South Korea 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 284: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Asia-Pacific Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Asia-Pacific Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Asia-Pacific Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Asia-Pacific Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 296: Latin America Recent Past, Current & Future Analysis for Pharmaceutical CRO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 297: Latin America Historic Review for Pharmaceutical CRO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Latin America 15-Year Perspective for Pharmaceutical CRO by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 299: Latin America Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Latin America Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Latin America 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 302: Latin America Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Latin America Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Latin America 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 305: Latin America Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Latin America Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Latin America 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 308: Latin America Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Latin America Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Latin America 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 311: Argentina Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Argentina Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Argentina 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 314: Argentina Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Argentina Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Argentina 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 317: Argentina Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Argentina Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Argentina 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 320: Argentina Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Argentina Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Argentina 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 323: Brazil Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Brazil Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Brazil 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 326: Brazil Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Brazil Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Brazil 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 329: Brazil Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Brazil Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Brazil 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 332: Brazil Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Brazil Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Brazil 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 335: Mexico Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Mexico Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Mexico 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 338: Mexico Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Mexico Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Mexico 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 341: Mexico Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Mexico Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Mexico 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 344: Mexico Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Mexico Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Mexico 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 347: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Rest of Latin America Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Rest of Latin America 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 350: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Rest of Latin America Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Rest of Latin America 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 353: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Rest of Latin America Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Rest of Latin America 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 356: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Rest of Latin America Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Rest of Latin America 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 359: Middle East Recent Past, Current & Future Analysis for Pharmaceutical CRO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 360: Middle East Historic Review for Pharmaceutical CRO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Middle East 15-Year Perspective for Pharmaceutical CRO by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 362: Middle East Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Middle East Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Middle East 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 365: Middle East Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Middle East Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Middle East 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 368: Middle East Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Middle East Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Middle East 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 371: Middle East Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Middle East Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Middle East 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 374: Iran Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Iran Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Iran 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 377: Iran Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Iran Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Iran 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 380: Iran Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Iran Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Iran 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 383: Iran Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Iran Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Iran 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 386: Israel Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Israel Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Israel 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 389: Israel Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Israel Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Israel 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 392: Israel Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Israel Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Israel 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 395: Israel Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Israel Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Israel 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 398: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Saudi Arabia Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Saudi Arabia 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 401: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Saudi Arabia Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Saudi Arabia 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 404: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Saudi Arabia Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Saudi Arabia 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 407: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Saudi Arabia Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Saudi Arabia 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 410: UAE Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: UAE Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: UAE 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 413: UAE Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: UAE Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: UAE 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 416: UAE Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: UAE Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: UAE 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 419: UAE Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: UAE Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: UAE 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 422: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Rest of Middle East Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 424: Rest of Middle East 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 425: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Rest of Middle East Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 427: Rest of Middle East 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 428: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Rest of Middle East Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 430: Rest of Middle East 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 431: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Rest of Middle East Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 433: Rest of Middle East 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030
• AFRICA
  • Pharmaceutical CRO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 434: Africa Recent Past, Current & Future Analysis for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Africa Historic Review for Pharmaceutical CRO by Type - Drug Discovery, Pre-Clinical and Clinical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 436: Africa 15-Year Perspective for Pharmaceutical CRO by Type - Percentage Breakdown of Value Sales for Drug Discovery, Pre-Clinical and Clinical for the Years 2015, 2025 & 2030
  • TABLE 437: Africa Recent Past, Current & Future Analysis for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Africa Historic Review for Pharmaceutical CRO by Service - Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 439: Africa 15-Year Perspective for Pharmaceutical CRO by Service - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Biostatistics, Investigator Payments, Laboratory, Patient & Site Recruitment, Technology, Other Services, Project Management / Clinical Supply Management, Data Management, Regulatory / Medical Affairs and Medical Writing for the Years 2015, 2025 & 2030
  • TABLE 440: Africa Recent Past, Current & Future Analysis for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Africa Historic Review for Pharmaceutical CRO by Therapeutic Areas - Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 442: Africa 15-Year Perspective for Pharmaceutical CRO by Therapeutic Areas - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • TABLE 443: Africa Recent Past, Current & Future Analysis for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Africa Historic Review for Pharmaceutical CRO by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 445: Africa 15-Year Perspective for Pharmaceutical CRO by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030

IV. COMPETITION